Jefferies & Company has upgraded Brightpoint CELL from Hold to buy and has established a $12.50 price target.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: UpgradesPrice TargetAnalyst RatingsbrightpointInformation TechnologyJefferies & CompanyTechnology Distributors
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in